BFRI

$0.00

(

0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Biofrontera Inc

NASDAQ | BFRI

0.95

USD

$0.00

(

0.00%

)

At Close (As of Oct 13, 2025)

$10.24M

Market Cap

-

P/E Ratio

-1.82

EPS

$1.25

52 Week High

$0.53

52 Week Low

HEALTHCARE

Sector

BFRI Chart

Recent Chart
Price Action

BFRI Technicals

Tags:

BFRI Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $19M
Total Revenue $37M
Cost Of Revenue $19M
Costof Goods And Services Sold $19M
Operating Income -$17M
Selling General And Administrative $34M
Research And Development $2.1M
Operating Expenses $36M
Investment Income Net -
Net Interest Income -$2.1M
Interest Income $71K
Interest Expense $2.1M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $1.1M
Income Before Tax -$18M
Income Tax Expense $22K
Interest And Debt Expense -
Net Income From Continuing Operations -$18M
Comprehensive Income Net Of Tax -
Ebit -$16M
Ebitda -$14M
Net Income -$18M

Revenue & Profitability

Earnings Performance

BFRI Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $22M
Total Current Assets $21M
Cash And Cash Equivalents At Carrying Value $5.9M
Cash And Short Term Investments $5.9M
Inventory $6.6M
Current Net Receivables $5.3M
Total Non Current Assets $1.4M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $35K
Intangible Assets Excluding Goodwill $35K
Goodwill -
Investments -
Long Term Investments -
Short Term Investments $7K
Other Current Assets $2.8M
Other Non Current Assets -
Total Liabilities $18M
Total Current Liabilities $12M
Current Accounts Payable $1.9M
Deferred Revenue -
Current Debt -
Short Term Debt $548K
Total Non Current Liabilities $5.6M
Capital Lease Obligations $824K
Long Term Debt $4.1M
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $4.9M
Other Current Liabilities $9.6M
Other Non Current Liabilities $23K
Total Shareholder Equity $4.4M
Treasury Stock -
Retained Earnings -$117M
Common Stock $9K
Common Stock Shares Outstanding $5.5M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$10M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $1.1M
Capital Expenditures $10K
Change In Receivables -
Change In Inventory $4.2M
Profit Loss -
Cashflow From Investment -$3K
Cashflow From Financing $15M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$18M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $19M
Total Revenue $37M
Cost Of Revenue $19M
Costof Goods And Services Sold $19M
Operating Income -$17M
Selling General And Administrative $34M
Research And Development $2.1M
Operating Expenses $36M
Investment Income Net -
Net Interest Income -$2.1M
Interest Income $71K
Interest Expense $2.1M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $1.1M
Income Before Tax -$18M
Income Tax Expense $22K
Interest And Debt Expense -
Net Income From Continuing Operations -$18M
Comprehensive Income Net Of Tax -
Ebit -$16M
Ebitda -$14M
Net Income -$18M

BFRI News

BFRI Profile

Biofrontera Inc Profile

Sector: HEALTHCARE

Industry: DRUG MANUFACTURERS - SPECIALTY & GENERIC

Biofrontera Inc. is a biopharmaceutical company focused on developing and marketing innovative dermatological products aimed at addressing various skin conditions. Headquartered in Woburn, Massachusetts, Biofrontera leverages its proprietary technologies to enhance treatment outcomes for patients in the United States. With a commitment to improving dermatological care, the company continues to expand its product offerings and aims to establish a stronger presence in the dermatology market.

VHAI
-25.00%
$0.00
YYAI
-12.69%
$0.16
STAI
+39.44%
$0.62
CGBS
-39.47%
$0.03
BURU
+6.25%
$0.50
PLUG
+13.30%
$3.87
ELBM
+334.95%
$7.17
GWH
+118.14%
$9.07
BITF
+28.33%
$5.39
RGTI
+20.26%
$52.82
NVDA
+2.98%
$188.62
ASST
-35.33%
$1.00
BYND
-48.50%
$1.03
IONZ
-35.04%
$2.21
NVTS
+23.51%
$10.16
JOBY
+2.94%
$16.76
ETHD
+16.10%
$3.82
DNN
+6.94%
$3.07
CAN
+33.93%
$1.45
SNAP
-7.15%
$7.78
QBTS
+23.97%
$40.93
INTC
+2.03%
$37.11
GPUS
-12.50%
$0.41
WULF
-0.58%
$13.51
F
+1.27%
$11.55
AXDX
-61.36%
$0.03
BBD
+1.30%
$3.10
CLF
+4.66%
$13.79
TSLA
+5.01%
$434.23
QS
+16.36%
$17.10
CRML
+56.07%
$23.38
NIO
+6.59%
$7.15
RR
-9.34%
$5.92
TLRY
-1.74%
$1.69
ACHR
+6.09%
$12.70
AMD
+0.40%
$215.76
PWM
+12.50%
$1.17
NAK
+29.80%
$2.63
SOUN
+10.25%
$19.14
RXRX
+4.41%
$5.55
ONDS
+17.24%
$10.81
CIFR
+19.77%
$20.32
MP
+21.94%
$95.52
LAES
+13.49%
$6.14
APLD
+2.14%
$34.71
BTBT
+5.58%
$3.97
VALE
-2.53%
$10.75
SOFI
+4.45%
$27.35
DVLT
-12.36%
$1.66
USAR
+17.01%
$38.15
IREN
+7.31%
$64.14
DFLI
+41.35%
$1.54
PFE
-0.30%
$24.70
WBD
-3.22%
$17.10
QUBT
+12.85%
$21.46
ABAT
+33.25%
$8.99
UUUU
+16.88%
$23.77
UAMY
+35.91%
$16.59
RMBL
+60.50%
$3.21
EOSE
+23.62%
$17.08
EPWK
-8.00%
$0.08
ADD
-25.47%
$0.05
ADAP
-0.64%
$0.18
CORZ
+2.66%
$18.52
XCH
+103.41%
$1.68
AAL
+1.51%
$11.69
RIG
+3.24%
$3.18
MARA
+9.43%
$20.40
TMQ
-9.46%
$5.93
NAKA
-4.05%
$0.83
BULL
+2.98%
$11.74
PLTR
+0.84%
$176.92
SRM
+53.27%
$10.30
NOK
-1.79%
$5.22
IONQ
+18.72%
$83.88
RF
+1.75%
$24.58
BMNR
+7.40%
$56.35
GDXD
-12.99%
$0.74
T
-1.06%
$25.59
QSI
+26.28%
$2.10
CLSK
+2.49%
$19.76
SMR
+14.72%
$45.02
BINI
-55.00%
$0.63
MULN
-55.00%
$0.63
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
AMZN
+1.81%
$220.30
AVGO
-5.90%
$324.63
ABEV
+1.18%
$2.13
NEHC
-8.12%
$2.60
WLGS
-5.57%
$0.04
BE
+26.54%
$109.93
BTG
+3.87%
$5.27
RGTZ
-50.00%
$9.30
WWR
0.00%
$1.98
TMC
+20.31%
$10.69
KDLY
-7.21%
$0.87
AMC
+0.68%
$2.95
ETWO
0.00%
$3.30
AAPL
+1.24%
$248.32
VHAI
-25.00%
$0.00
YYAI
-12.69%
$0.16
STAI
+39.44%
$0.62
CGBS
-39.47%
$0.03
BURU
+6.25%
$0.50
PLUG
+13.30%
$3.87
ELBM
+334.95%
$7.17
GWH
+118.14%
$9.07
BITF
+28.33%
$5.39
RGTI
+20.26%
$52.82
NVDA
+2.98%
$188.62
ASST
-35.33%
$1.00
BYND
-48.50%
$1.03
IONZ
-35.04%
$2.21
NVTS
+23.51%
$10.16
JOBY
+2.94%
$16.76
ETHD
+16.10%
$3.82
DNN
+6.94%
$3.07
CAN
+33.93%
$1.45
SNAP
-7.15%
$7.78
QBTS
+23.97%
$40.93
INTC
+2.03%
$37.11
GPUS
-12.50%
$0.41
WULF
-0.58%
$13.51
F
+1.27%
$11.55
AXDX
-61.36%
$0.03
BBD
+1.30%
$3.10
CLF
+4.66%
$13.79
TSLA
+5.01%
$434.23
QS
+16.36%
$17.10
CRML
+56.07%
$23.38
NIO
+6.59%
$7.15
RR
-9.34%
$5.92
TLRY
-1.74%
$1.69
ACHR
+6.09%
$12.70
AMD
+0.40%
$215.76
PWM
+12.50%
$1.17
NAK
+29.80%
$2.63
SOUN
+10.25%
$19.14
RXRX
+4.41%
$5.55
ONDS
+17.24%
$10.81
CIFR
+19.77%
$20.32
MP
+21.94%
$95.52
LAES
+13.49%
$6.14
APLD
+2.14%
$34.71
BTBT
+5.58%
$3.97
VALE
-2.53%
$10.75
SOFI
+4.45%
$27.35
DVLT
-12.36%
$1.66
USAR
+17.01%
$38.15
IREN
+7.31%
$64.14
DFLI
+41.35%
$1.54
PFE
-0.30%
$24.70
WBD
-3.22%
$17.10
QUBT
+12.85%
$21.46
ABAT
+33.25%
$8.99
UUUU
+16.88%
$23.77
UAMY
+35.91%
$16.59
RMBL
+60.50%
$3.21
EOSE
+23.62%
$17.08
EPWK
-8.00%
$0.08
ADD
-25.47%
$0.05
ADAP
-0.64%
$0.18
CORZ
+2.66%
$18.52
XCH
+103.41%
$1.68
AAL
+1.51%
$11.69
RIG
+3.24%
$3.18
MARA
+9.43%
$20.40
TMQ
-9.46%
$5.93
NAKA
-4.05%
$0.83
BULL
+2.98%
$11.74
PLTR
+0.84%
$176.92
SRM
+53.27%
$10.30
NOK
-1.79%
$5.22
IONQ
+18.72%
$83.88
RF
+1.75%
$24.58
BMNR
+7.40%
$56.35
GDXD
-12.99%
$0.74
T
-1.06%
$25.59
QSI
+26.28%
$2.10
CLSK
+2.49%
$19.76
SMR
+14.72%
$45.02
BINI
-55.00%
$0.63
MULN
-55.00%
$0.63
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
AMZN
+1.81%
$220.30
AVGO
-5.90%
$324.63
ABEV
+1.18%
$2.13
NEHC
-8.12%
$2.60
WLGS
-5.57%
$0.04
BE
+26.54%
$109.93
BTG
+3.87%
$5.27
RGTZ
-50.00%
$9.30
WWR
0.00%
$1.98
TMC
+20.31%
$10.69
KDLY
-7.21%
$0.87
AMC
+0.68%
$2.95
ETWO
0.00%
$3.30
AAPL
+1.24%
$248.32
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.